OTC Focused Trader. all imo & not financial advice. Only a trader knows euphoria and depression on the same trading day.
Guanacaste Costa Rica
Joined January 2019
- Tweets6.4K
- Following3.3K
- Followers4.5K
- Likes8.6K
From the press release, we know that 150M was allocated for debt settlement. The share issuances since September 28th equal 147M. Is that what those shares are for? We'll just have to watch the share structure to find out. I wish Oscar was more trustworthy than a pos. $UGIZ
Lake Maracaibo is where $UGIZ will be operating. Don't be surprised if we see a partnership involving Chevron or PDVSA. Think about the affect on price. I'm not happy about the increasing SS. Even at 1B OS, a move to .03–.04 is still very possible.Plentiful work with good margins
$UGIZ is settling & restructuring debt. We know 150m was allocated for this purpose. So seeing the share structure increase is no surprise. In Venezuela, well reworks will run between $250k to $1m each. Do the math. Even if the SS increases by another 400m, it's still undervalued
$UGIZ oil services in Venezuela sets Crossfield energy as an 02 plus stock if they would quit just f****** around. If Oscar would have just gotten a deal where the debt was settled or canceled this thing would be a hell of a lot higher. There is big money in the energy sector
Oil service co's will be charging a lot for work in Venezuela. You're looking at a co that's going to be valued at well over 20M. So just do the math. $UGIZ will work through this price range and break 01. We just have to work through old insiders, scumbags, the typical crowd.
"AO Capital Partners prioritized the restructuring and conversion of a significant portion of the legacy convertible debt"
Significant portion ? I thought all the debt was locked up at 01?
Congratulations to Javier.
Sounds like the debt is not fully cleared. $UGIZ
1/2 JL-112 originated with Dr. Alvin Pettle’s work at $HADV. HADV and Dr. Pettle created a special entity to pursue FDA approval and commercialization. JASTLabs is now advancing the drug through patents, regulatory development and commercialization. HADV has an economic interest.
2/2 JASTLabs carries a stated $160M val and is allocating 10% of $75m toward $HADV, receiving preferred shares. 5 Pettle linked individuals have positions across the 2 co's, from JAST co-founder & HADV lead scientist to noteholders. HADV's economic interest worth? 10% of $160m.
The problem is OTCN. Because Oscar is dangling a carrot. But as this is delayed, that carrot keeps on getting smaller and smaller as the share structure expands. He pulled this same stunt with GNIS. dangled the carrot while the share structure expanded.
$UGIZ
$UGIZ Patience is a virtue and our shareholders have shown plenty of it. Thank you. The UGIZ transaction remains firmly on track, most open items have been resolved, and we're working through the final steps. We'll announce as soon as it's formally done. Almost there.
Interesting part is that JSATLabs & Rubin think that they can take the company public on this product. So if they're raising $75 million at $2 apiece with $HADV holding an economic stake in it. JAST investing 10% of their $75M in HADV makes sense. DD DONE...
Imo, the $HADV/JASTLabs relationship isn't a funding arrangement. HADV disclosed a financial relationship with a pharmaceutical product, & JAST is now raising capital to develop & commercialize its product. HADV participates economically in the JAST product. JAST invests in HADV.
Doing some quick due diligence, and I was wondering why JASTLabs would be giving money to $HADV. And I found some connections, and the product might be significant.
jastlabs.com/team
manhattanstreetcapital.com/j…
$NXGB $TIPS $SEII $MASN
$BDPT It's a mixed bag on news. The new share count is going to be around 652 million, but it does take BDPT from a nutraceutical company into more of the biotech.